Skip directly to site content Skip directly to page options Skip directly to A-Z link


Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People
														Search
		×
			NIOSH
			NIOSH
				All CDC
				Submit
			For a full list of topics:A-Z Index
			Advanced Search
		Advanced Search


The National Institute for Occupational Safety and Health (NIOSH)


Facebook
        Twitter
        LinkedIn
        Syndicate





ZIRCONIUM COMPOUNDS								Related Pages
										*OSHA comments from the January 19, 1989 Final Rule on Air Contaminants Project extracted from 54FR2332 et. seq. This rule was remanded by the U.S. Circuit Court of Appeals and the limits are not currently in force.*
**CAS:** 7440-67-7; **Chemical Formula:** Zr
The former OSHA limit for zirconium compounds was an 8-hour TWA of 5 mg/m3, measured as zirconium. The ACGIH has established a TLV-TWA of 5 mg/m3, supplemented by a 10 mg/m3 STEL, (as Zr). The proposal retained the 8-hour TWA but added a STEL of 10 mg/m3; these limits are promulgated by the final rule. Zirconium compounds may be either bluish-black powders or grayish-white lustrous metals.
The toxic effects of inhalation exposures to zirconium compounds include the formation of granulomas, both in the lungs and on the skin. Sax (Dangerous Properties of Industrial Materials, 6th ed., 1984) reports cases of pulmonary granulomas in workers exposed to zirconium aerosols. In laboratory animals, oral toxicity is low (NIOSH 1972b, as cited in ACGIH 1986/Ex. 1-3, p. 647), and inhalation studies conducted for one year at levels of 3.5 mg zirconium/m3 dust and mist resulted in limited toxicity (Stokinger 1981c/Ex. 1-1134).
NIOSH (Ex. 8-47) recommended that zirconium tetrachloride should not be included among the compounds for which the proposed zirconium PEL is applied. NIOSH cites an animal study by Spiegl et al. (1956, as cited in ACGIH 1986/Ex. 1-3, p. 647), in which a 60-day exposure to zirconium tetrachloride at a concentration of 6 mg/m3 (six hours/day, five days/week) resulted in increased mortality in rats and guinea pigs and a decrease “of borderline significance” in blood hemoglobin and red blood cell levels in dogs. Given that the observed effect level for mortality of 6 mg/m3 is close to the proposed 5 mg/m3 limit, NIOSH (Ex. 8-47) stated that a separate PEL should be considered for zirconium tetrachloride.
At this time, OSHA is establishing the PELs as proposed for all zirconium compounds, including zirconium tetrachloride. There are no reports, other than the one cited by NIOSH, that indicate that exposure to zirconium compounds causes severe toxicity at levels near the proposed 5 mg/m3 TWA PEL; in addition, the toxic reaction of dogs exposed to 6 mg/m3 was of borderline significance.
OSHA concludes that the 5 mg/m3 TWA and 10 mg/m3 STEL limits for the zirconium compounds, measured as zirconium, will protect workers from the significant risk of pulmonary effects potentially associated with the short-term exposures permitted by the 8-hour TWA alone. The Agency has determined that these effects constitute material health impairments.
										
							
								Page last reviewed:  September 28, 2011						Content source:  	National Institute for Occupational Safety and Health NIOSH
1988 OSHA PEL Project Documentation
Index of Chemical Names
Index of CAS Numbers Follow NIOSH Facebook
Pinterest
Twitter
YouTube
 NIOSH Homepage NIOSH A-Z
Workplace Safety & Health Topics
Publications and Products
Programs
Contact NIOSH


About CDC
					Contact Us
					800-232-4636
 Facebook Twitter Instagram LinkedIn Youtube Pinterest Snapchat
 CONTACT CDC
				Contact Us
							Call 800-232-4636
							Email Us
			ABOUT CDC
				About CDC
							Jobs
							Funding
			POLICIES
				Accessibility
							External Links
							Privacy
							Policies
							No Fear Act
							FOIA
							OIG
							Nondiscrimination
							Vulnerability Disclosure Policy
			CONNECT WITH US
				Facebook
								Twitter
								Instagram
								LinkedIn
							Youtube
								Pinterest
								Snapchat
								Email
			LANGUAGES
				Español
							繁體中文
							Tiếng Việt
							한국어
							Tagalog
							Русский
							العربية
							Kreyòl Ayisyen
							Français
							Polski
							Português
							Italiano
							Deutsch
							日本語
							فارسی
							English


U.S. Department of Health & Human Services
			Accessibility
			External Links
			Privacy
			Policies
			No Fear Act
			FOIA
			Nondiscrimination
			OIG
			Vulnerability Disclosure Policy
			USA.gov


Exit Notification / Disclaimer Policy Close
 Links with this icon  indicate that you are leaving the CDC website. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
				Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
				You will be subject to the destination website's privacy policy when you follow the link.
				CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. Website Disclaimers
 Cancel Continue